Literature DB >> 11713926

Effects of sildenafil on esophageal motility of normal subjects.

M Bortolotti1, C Mari, M Giovannini, S Pinna, M Miglioli, N Pandolfo.   

Abstract

Sildenafil shows an intense and prolonged inhibitory effect on the smooth muscle cells of corpus cavernosum arterioles by blocking phosphodiesterase type 5 that inactivates the nitric oxide-stimulated cyclic guanosine monophosphate. We investigated if this inhibitory effect is also displayed on smooth muscle cells of the esophagus. In 16 normal subjects (9 men and 7 women, mean age 34 years, range 22-56) esophageal motility was recorded by means of a low-compliance manometric system with side holes for the esophageal body and a sleeve for the lower esophageal sphincter (LES). After a basal period of 60 min, a tablet of sildenafil 50-mg ground and dissolved in water was infused in the stomach in eight subjects (group A) and a placebo tablet in the other eight subjects (group B), randomly and in a double-blind manner; the recording continued for another 60 min. LES tone and postdeglutitive residual pressure, as well as amplitude, propagation velocity, and onset latency of contractions were measured each minute, the values averaged every 5 min, and the mean of the entire basal and postinfusion periods was calculated. The postinfusion values were compared with the basal values in each group and with the corresponding values of the other groups. The percent variations of postinfusion values with respect to basal values were also compared. Sildenafil induced a statistically significant decrease of LES tone, residual pressure, wave amplitude, and propagation velocity and a significant increase of onset latency of pressure waves in comparison with the values of the basal period and placebo. The inhibitory effect reached its maximum 10-15 min after the infusion and lasted about 1 hr. In conclusion, sildenafil markedly inhibits the motor activity of the esophageal musculature by decreasing LES pressure, wave amplitude, and propagation velocity and increasing the onset latency of pressure waves.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11713926     DOI: 10.1023/a:1012383424783

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

Authors:  I Goldstein; T F Lue; H Padma-Nathan; R C Rosen; W D Steers; P A Wicker
Journal:  N Engl J Med       Date:  1998-05-14       Impact factor: 91.245

2.  Effects of sildenafil on esophageal motility of patients with idiopathic achalasia.

Authors:  M Bortolotti; C Mari; C Lopilato; G Porrazzo; M Miglioli
Journal:  Gastroenterology       Date:  2000-02       Impact factor: 22.682

3.  Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells.

Authors:  R B Moreland; I Goldstein; A Traish
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

4.  Role of nitric oxide in esophageal peristalsis in the opossum.

Authors:  S Yamato; S J Spechler; R K Goyal
Journal:  Gastroenterology       Date:  1992-07       Impact factor: 22.682

5.  Role of nitric oxide in esophageal peristalsis.

Authors:  N Anand; W G Paterson
Journal:  Am J Physiol       Date:  1994-01

6.  The effects of recombinant human hemoglobin on esophageal motor functions in humans.

Authors:  J A Murray; A Ledlow; J Launspach; D Evans; M Loveday; J L Conklin
Journal:  Gastroenterology       Date:  1995-10       Impact factor: 22.682

7.  Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

Authors:  M Boolell; M J Allen; S A Ballard; S Gepi-Attee; G J Muirhead; A M Naylor; I H Osterloh; C Gingell
Journal:  Int J Impot Res       Date:  1996-06       Impact factor: 2.896

8.  Mechanisms of gastroesophageal reflux in patients with reflux esophagitis.

Authors:  W J Dodds; J Dent; W J Hogan; J F Helm; R Hauser; G K Patel; M S Egide
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

9.  A wave of inhibition precedes primary peristaltic contractions in the human esophagus.

Authors:  D Sifrim; J Janssens; G Vantrappen
Journal:  Gastroenterology       Date:  1992-09       Impact factor: 22.682

Review 10.  Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction.

Authors:  M M Goldenberg
Journal:  Clin Ther       Date:  1998 Nov-Dec       Impact factor: 3.393

View more
  4 in total

1.  Esophageal motility disorders (distal esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter): modern management.

Authors:  Radu Tutuian; Donald O Castell
Journal:  Curr Treat Options Gastroenterol       Date:  2006-07

2.  A pilot study of the effects of sildenafil on stool characteristics, colon transit, anal sphincter function, and rectal sensation in healthy men.

Authors:  Mark Milone; John K DiBaise
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

3.  Examination of the effects of vardenafil on esophageal function using multichannel intraluminal impedance and manometry.

Authors:  Tae Hee Lee; Joon Seong Lee; Su Jin Hong; Seong Ran Jeon; Wan Jung Kim; Hyun Gun Kim; Joo Young Cho; Jin-Oh Kim
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

4.  Gut disease in systemic sclerosis - new approaches to common problems.

Authors:  Jessica Zhu; Tracy Frech
Journal:  Curr Treatm Opt Rheumatol       Date:  2019-02-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.